CLINICAL/HORMONAL EFFECTS OF GHRP-2 IN ARTHRITIS/LUPUS/FIBROMYALGIA

GHRP-2 对关节炎/狼疮/纤维肌痛的临床/激素影响

• 批准号: 6122160
• 负责人: CYRIL Y BOWERS
• 金额: $ 1.12万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-07-19 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6122160
• 关键词: adrenocorticotropic hormone; clinical research; clinical trial phase I; connective tissue disorder chemotherapy; cortisol; endocrine pharmacology; fibromyalgia; growth hormone releasing hormone; human subject; human therapy evaluation; rheumatoid arthritis; somatotropin; synthetic peptide; systemic lupus erythematosus

The purpose of the study will be to determine whether GHRP-2 subcutaneously can stimulate growth hormone secretion. ACTH (a hormone from the pituitary) and Cortisol are used to lessen the primary symptoms of musculoskeletal pain, stiffness, and tenderness. This study is to determine how GHRP-2 will effect patients with rheumatoid arthritis, fibromyalgia, and lupus.

该研究的目的将是确定是否GHRP-2皮下可以刺激生长激素分泌。 促肾上腺皮质激素（一种来自脑垂体的激素）和皮质醇用于减轻肌肉骨骼疼痛、僵硬和压痛的主要症状。 这项研究是为了确定如何GHRP-2将影响类风湿性关节炎，纤维肌痛，和狼疮患者.